

Cover Story
Free
By Matthew Bin Han Ong
FDA has created a framework for evaluating the use of real-world evidence to support additional indications for already approved drugs as well as to satisfy drug post-marketing study requirements.
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for January
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- Otis Brawley looks back on a year of great science and greater challenges
- Elisa Rodriguez named first chief diversity and equity officer for faculty at Roswell Park
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Gregory Curt, Clinician and Drug Developer, Dies at 64
- Twitter star Vinay Prasad retires @VinayPrasadMD
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program

















